A large-scale clinical trial combining two popular lung cancer drugs Tarceva and Avastin has showed no increase in survival rates.

However, the combination treatment kept the disease from progressing for a longer period than Tarceva alone, the study found. Tarceva is marketed by Genentech and Avastin by Roche. Roche Holding AG sells both drugs in Europe

Three European scientists have shared the 2008 Nobel prize for medicine.

Two French scientists Luc Montagnier, director of the World Foundation for AIDS Research and Prevention, and Francoise Barre-Sinoussi, of the Institut Pasteur, discovered the AIDS virus. They won half the prize of 10 million Swedish crowns (US$1.4-million) for discovering the deadly virus

Herpes simplex virus that causes genital herpes has infected more than half a billion people and nearly 24 million new cases happen per year, World Health Organization (WHO) said in a new study.

In the first global estimate of the prevalence and incidence of this incurable disease by herpes simplex virus type 2 (HSV-2) infection, researchers found that 536 million people aged 15-49 are infected with it, which makes it 16 percent of people in that age range

Women who take hormone replacement therapy (HRT) do not face an increased risk of heart attack, a new study confirms.

Though the breast cancer experts recommend avoiding or limiting hormone replacement therapy, but a new study by Danish researchers suggests that if a woman uses a cream or skin patch or takes alternate hormone combinations, the risk of heart attack is less

With a large number of children waiting for heart transplants, researchers have now developed miniature pumps known as ventricular assist devices to help them bridge the gap to transplantation.

The device, which has been successfully used in children younger than 5, takes over for a damaged heart and helps keep the patient alive as they wait for a long time until a donated organ is available, a study found